These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31166544)

  • 21. Predictors of symptomatic remission in first-episode psychosis outpatients treated with quetiapine: a naturalistic study.
    Gade K; Köhler J; Klein P; Falkai P; Wobrock T
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):148-53. PubMed ID: 22746987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schneider's first-rank symptoms have neither diagnostic value for schizophrenia nor higher clinical validity than other delusions and hallucinations in psychotic disorders.
    Peralta V; Cuesta MJ
    Psychol Med; 2023 Apr; 53(6):2708-2711. PubMed ID: 32943125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
    Zhang JP; Robinson D; Yu J; Gallego J; Fleischhacker WW; Kahn RS; Crespo-Facorro B; Vazquez-Bourgon J; Kane JM; Malhotra AK; Lencz T
    Am J Psychiatry; 2019 Jan; 176(1):21-28. PubMed ID: 30392411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
    Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
    Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of Schneider's first rank symptoms for schizophrenia in Malay patients.
    Salleh MR
    Psychopathology; 1992; 25(4):199-203. PubMed ID: 1492143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of early remission of positive symptoms in first treated psychosis.
    Norman RM; Manchanda R; Windell D
    Psychiatry Res; 2014 Aug; 218(1-2):44-7. PubMed ID: 24780449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting prognosis in patients with first-episode psychosis using auditory P300: A 1-year follow-up study.
    Lho SK; Kim M; Lee TH; Kwak YB; Kwon JS
    Clin Neurophysiol; 2019 Jan; 130(1):46-54. PubMed ID: 30476710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.
    Berger M; Juster RP; Westphal S; Amminger GP; Bogerts B; Schiltz K; Bahn S; Steiner J; Sarnyai Z
    Psychoneuroendocrinology; 2018 Apr; 90():35-42. PubMed ID: 29427955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis.
    Carlsson R; Nyman H; Ganse G; Cullberg J
    Acta Psychiatr Scand; 2006 Feb; 113(2):102-11. PubMed ID: 16423161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical recovery in first-episode psychosis.
    Wunderink L; Sytema S; Nienhuis FJ; Wiersma D
    Schizophr Bull; 2009 Mar; 35(2):362-9. PubMed ID: 18990715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study.
    Crespo-Facorro B; de la Foz VO; Ayesa-Arriola R; Pérez-Iglesias R; Mata I; Suarez-Pinilla P; Tabares-Seisdedos R; Vázquez-Barquero JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():162-7. PubMed ID: 23435091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
    Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
    J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An early improvement threshold to predict response and remission in first-episode schizophrenia.
    Schennach-Wolff R; Seemüller FH; Mayr A; Maier W; Klingberg S; Heuser I; Klosterkötter J; Gastpar M; Häfner H; Sauer H; Schneider F; Gaebel W; Jäger M; Möller HJ; Riedel M
    Br J Psychiatry; 2010 Jun; 196(6):460-6. PubMed ID: 20513856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
    Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shall we really say goodbye to first rank symptoms?
    Heinz A; Voss M; Lawrie SM; Mishara A; Bauer M; Gallinat J; Juckel G; Lang U; Rapp M; Falkai P; Strik W; Krystal J; Abi-Dargham A; Galderisi S
    Eur Psychiatry; 2016 Sep; 37():8-13. PubMed ID: 27429167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.